These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329 [TBL] [Abstract][Full Text] [Related]
74. OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes. Liao Y; Luo Z; Deng Y; Zhang F; Rao R; Wang J; Xu L; Kumar SS; Sengupta S; DeWire-Schottmiller M; Berry K; Garrett M; Fouladi M; Drissi R; Lu QR Neuro Oncol; 2021 Jul; 23(7):1183-1196. PubMed ID: 33539525 [TBL] [Abstract][Full Text] [Related]
75. Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore. Hollingworth MA; Zacharoulis S J Neurooncol; 2020 Sep; 149(2):263-272. PubMed ID: 32902768 [TBL] [Abstract][Full Text] [Related]